Similarly, the overexpression of MEG3 downregulates the expression of N-cadherin, Vimentin, and Snail, while silencing MEG3 increases the expression of these markers in glioma cells [48] and cholangiocarcinoma cells [49]. Here, MEG3 is linked to central nervous system cancer.